FIELD: pharmacology.
SUBSTANCE: pharmaceutical composition for treatment or prevention of pancreatic cancer expressing CAPRIN-1, contains an antibody or a fragment thereof in an effective amount that have specific immunological reactivity to the CAPRIN-1 protein, or a conjugate of an antibody or fragment thereof with an antitumor means in an effective amount as an active ingredient, as well as a pharmaceutical combination containing it. A method for treatment or prevention of pancreatic cancer expressing CAPRIN-1, comprising administration of the aforementioned pharmaceutical composition or the aforementioned pharmaceutical combination is also disclosed.
EFFECT: invention allows to effectively implement treatment or prevention of pancreatic cancer expressing CAPRIN-1.
8 cl, 8 ex
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT AND PREVENTION | 2012 |
|
RU2641260C2 |
PHARMACEUTICAL COMPOSITION FOR TREATING AND/OR PREVENTING MALIGNANT GROWTH | 2012 |
|
RU2595400C2 |
PHARMACEUTICAL COMPOSITION FOR TREATING AND/OR PREVENTING MALIGNANT GROWTH | 2012 |
|
RU2610428C2 |
PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT AND/OR PREVENTION | 2012 |
|
RU2611197C2 |
PHARMACEUTICAL COMPOSITION FOR TREATMENT AND/OR PREVENTION OF GALLBLADDER CANCER | 2013 |
|
RU2649802C2 |
PHARMACEUTICAL COMPOSITION FOR LIVER CANCER TREATMENT AND/OR PREVENTION | 2013 |
|
RU2640245C2 |
PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT AND PREVENTION | 2012 |
|
RU2624049C2 |
PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT OR PREVENTION | 2013 |
|
RU2631804C2 |
PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT AND/OR PREVENTION | 2013 |
|
RU2633505C2 |
PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT AND/OR PREVENTION | 2013 |
|
RU2632645C2 |
Authors
Dates
2017-09-11—Published
2012-08-03—Filed